Latest Share Purchase Plans News

Acrow Limited has raised $16 million through an oversubscribed Share Purchase Plan, exceeding its $10 million underwriting target. The additional funds will be directed towards debt reduction, reinforcing the company’s financial position ahead of a pending placement approval.

Ardea Resources pushes back the completion of its Kalgoorlie Nickel Project DFS to pursue optimisation opportunities, while securing strong multi-level government backing and maintaining a robust financial position.

Wrkr Ltd has completed a $10 million placement and launched a $2 million Share Purchase Plan to fund accelerated employer onboarding and platform enhancements ahead of Payday Super’s phased rollout.

CONNEQT Health's June quarter saw record consumer revenue growth and a 70% jump in enterprise subscription ARR, supported by a $5.5 million placement and progress on its FDA regulatory pathway for its cloud-based vascular analytics platform.

Recce Pharmaceuticals secured a non-binding term sheet with a major Middle Eastern pharma for its diabetic foot infection treatment and raised A$4 million to fund pivotal Phase 3 trials in Australia and Indonesia.

Control Bionics has closed its Share Purchase Plan, raising $256,500 and pushing total capital raised to $9.75 million, pending shareholder approval for the final tranche.

ClearVue Technologies has exceeded its $1 million target in a Share Purchase Plan, raising $1.29 million and issuing over 14.6 million shares with free attaching options pending shareholder approval.

Comet Ridge Limited has pushed back the closing date for its Share Purchase Plan and associated Options Offers to 24 July 2026, giving eligible shareholders more time to participate ahead of a key August meeting.

Microba Life Sciences has delivered robust FY26 growth in its core microbiome testing business, with revenues up 92% year-on-year and a new GI Navigator product set for launch in September 2026. The company also announced a $7 million annualised cost reduction program as it advances towards cashflow break-even.

Tāiko Critical Minerals has raised $7 million through an oversubscribed placement, exceeding its $5 million target, to fund development of its Barrytown Critical Minerals Project. A share purchase plan will soon offer existing shareholders the chance to buy shares at the same price.

Western Yilgarn NL (ASX: WYX) is offering eligible shareholders in Australia and New Zealand a chance to buy up to $30,000 in new shares at 3 cents each, sweetened with free attaching options exercisable at 10 cents. The company aims to raise $500,000 to fund exploration and working capital.

Arafura Rare Earths has secured $361.5 million before costs through a combined placement and share purchase plan, issuing approximately 44.4 million new shares under the SPP and leaving a notable shortfall.